(Q40989781)

25 September 2017

A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo (English)

1 reference

25 September 2017

0 references

Kuwabara T

1

1 reference

25 September 2017

Warashina M

2

1 reference

25 September 2017

Tanabe T

3

1 reference

25 September 2017

Tani K

4

1 reference

25 September 2017

Asano S

5

1 reference

25 September 2017

Taira K

6

1 reference

25 September 2017

1 November 1998

1 reference

25 September 2017

1 reference

25 September 2017

2

1 reference

25 September 2017

5

1 reference

25 September 2017

617-627

1 reference

The structure, function and application of the hammerhead ribozyme

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Role of divalent metal ions in the hammerhead RNA cleavage reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Simple RNA enzymes with new and highly specific endoribonuclease activities

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Role of polyadenylation in nucleocytoplasmic transport of mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Selection of the best target site for ribozyme-mediated cleavage within a fusion gene for adenovirus E1A-associated 300 kDa protein (p300) and luciferase.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Efficient screening of retroviral cDNA expression libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

A simple assay system for examination of the inhibitory potential in vivo of decoy RNAs, ribozymes and other drugs by measuring the Tat-mediated transcription of a fusion gene composed of the long terminal repeat of HIV-1 and a gene for luciferase

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Sequence specificity on the growth suppression and induction of apoptosis of chronic myeloid leukemia cells by BCR-ABL anti-sense oligodeoxynucleoside phosphorothioates

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Minimal sequence requirements for ribozyme activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

An allosteric hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

A general two-metal-ion mechanism for catalytic RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Self-cleavage of RNA in the replication of small pathogens of plants and animals

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Rational design of allosteric ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

A small catalytic oligoribonucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

The Hydrolysis of RNA: From Theoretical Calculations to the Hammerhead Ribozyme-Mediated Cleavage of RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2800%2980160-4

7 January 2021

10.1016/S1097-2765(00)80160-4

Identifiers

DOI

1 reference

release_3ijhz7wj2fbwlobhfph7pkfu2e

25 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ijhz7wj2fbwlobhfph7pkfu2e

24 November 2022

mapped directly with Wikidata item

1 reference